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1. Introduction 
Type IV collagens are major constituents of base- 
ment membranes and possess afairly rigid triple 
helical conformation exceeding in length those found 
in interstitial collagens [ 1,2]. This triple helix makes 
interstitial collagens highly resistant to proteolytic 
cleavage except for the release of short non-helical seg- 
ments from both ends of the a! chains (M, 95 000) 
[3]. In contrast, a variety of fragments ranging 
between Mr 27 000 and 140 000 could be produced 
by pepsin cleavage of type IV collagen from kidney 
glomeruli [4,5], placenta [6-91, lens capsule [lO,l l] 
and a tumor matrix [ 121. This data suggested that 
the triplet sequence Gly-X-Y, which is considered 
to be essential for a stable triple helical conformation 
[ 131, is frequently interrupted. 
This possibility was examined by sequence analysis 
of the pepsin fragment Pl (A$ 55 000) obtained from 
type IV collagen extracted from a mouse tumor [ 121. 
Pl is a fragment of a longer chain (ol (IV) or C chain) 
obtained from a variety of sources [5,6,9-l 11. Previ- 
ous studies have established that the first 8 residues at 
the N-terminus of peptide Pl do not resemble the Gly- 
X-Y type of sequence [ 121. Here, results obtained 
for various fragments ofPl demonstrate hat the triple 
helix of type IV collagen is interrupted by longer 
stretches of non-helical sequences as well as by dele- 
tions of single glycine residues. The data explain the 
sensitivity of type IV collagen to pepsin and other 
non-collagenolytic proteases which produce a number 
of well-defined, relatively stable intermediates, the 
size of which depends upon the conditions of the 
cleavage reaction [12,14]. 
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2. Experimental 
The pepsin fragment Pl of type IV collagen was 
obtained from a mouse tumor and purified as in [ 121. 
This fragment was treated with mercaptoethanol [ 151 
prior to cleavage with cyanogen bromide (CNBr) in 
70% formic acid [ 161. Further treatments of CNBr 
peptides included digestion with thermolysin [173 for 
4 h at 37°C. Peptides were purified by chromatog- 
raphy on phosphocellulose [16], on Sephadex G-75s 
(column 2 X 140 cm) equilibrated in 0.03 M sodium 
acetate (PH 4.8) at 4O”C, and on columns of Bio-Gel 
P4 and P-2 equilibrated in 0.2 M ammonium bicar- 
bonate (pH 8.5). For amino acid analysis on aDurrum 
D500 analyzer purified peptides were hydrolyzed with 
6 M HCl(24 h, 110°C) under Nz. 
Sequence analysis of peptides (50-200 m-nol) was 
carried out by automated Edman degradation i a 
Beckman sequencer, model 890C [14,18]. Phenyl- 
thiohydantoin derivatives released uring sequencing 
were identified by high-pressure liquid chromatog- 
raphy (HPLC) (Spectra Physics, model SP8000) using 
an isocratic elution system or by thin-layer chromatog- 
raphy (TLC). 
3. Results 
Pepsin fragment Pl (-540 amino acid residues, 
table 1) which comprises a major portion of the mouse 
type IV collagen crl (IV) chain [12] was subjected to 
CNBr cleavage and the digest separated on Sephadex 
G-75 (fig.1). This allowed the partial separation and 
further purification of 9 individual peptides (CBl- 
CB9) varying in size from 3- 140 amino acid residues 
[20]. The methionine content of Pl would indicate 
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Table 1 
Amino acid composition of pepsin fragment Pl and its 
CNBr peptides CBS and CB7 (residueslpeptide) 
Pl CBS CBI 
3-HYP 2.1 
4-HYP 68 
Asp 28 
Thr 12 
Ser 29 
Glu 48 
Pro 31 
Gly 174 
Ala 13 
Val 19 
Met 5.9 
Be 12 
Leu 23 
Tyr 1.0 
Phe 14 
His 4.6 
Hyl 33 
Lys 3.2 
Anr 1.2 
- 
8.3 
3.1 
1.0 
1 .o 
6.1 
5.0 
15.0 
1.0 
1.4 
1.4a 
0.7 
2.1 
- 
1.8 (2)b 
0.9 (1) 
0.9 (1) 
1.4 (2) 
- 
0.9 (1) 
3.4 (3) 
-0.7 (1) 
0.3a 
0.3 
- - 
1.1 0.5 (1) 
- 0.6 (1) 
1.8 - 
Total 535 48 12 (13) 
a As homoserine. A dash denotes <0.2 residues 
b Values determined by sequence analysis 
200 300 400 
Effluent volume. ml 
Fig.1. Fractionation of a CNBr digest of the pepsin fragment 
Pl on Sephadex G-75 (a) and separation of peptides CB4 and 
CB5 on phosphocelhdose (b). The Sephadex G-75 column 
(2 X 140 cm) was ~~b~te~ in 0.03 M sodium acetate 
(pH 4.8) at 40°C. The phosphocellulose column (1.5 X 10 
cm) was equilibrated at 40°C in 0.001 M sodium acetate 
(pH 3.6) and eluted with a linear gradient (150/l 50 ml) from 
O-O.4 M NaCI. Numbers in brackets refer to relative amounts 
of peptide material (in %) recovered in the particular peak. 
Peaks without designation contained incompletely cleaved 
CNBr peptides. Tv in (a) denotes the total column volume 
and G in @) the start of the gradient. 
the existence of 7 CNBr peptides but part of the 
methionine in basement membrane proteins is usually 
oxidized [213 and requires reduction [15 J for efficient 
cleavage with CNBr [9,20]. Two of the CNBr peptides 
of Pl were subjected to more extensive sequence 
analysis. These included peptide CB5 which was sep- 
arated from peptide CB4 on phosphocellulose (fig. 1). 
Amino acid analysis (table 1) as well as molecular 
sieve chromatography showed that the peptide con- 
sists of -48 amino acid residues including one homo- 
se&e. The second peptide CB7 contained 13 amino 
acid residues and was purified by chromatography on 
Bio-Gel P-4 and phosphocellulose. Since CB7 lacks 
homoserine it originates from the C-terminus of frag 
ment Pl. 
Sequence analysis (fig.21 of Pl demonstrated as 
shown before [ 121, that the first 8 ammo acid residues 
lack glycine in every third position but the continuing 
sequence was of the Gly-X-Y type. The positions 
of -30 amino acid residues were determined by 
Edman degradation of peptide CBS and of fragments 
obtained by thermolysine digestion which mainly 
cleaves at position 18-19 of CBS. This sequence 
began with six triplets Gly-X-Y, was interrupted by 
Val-Glu and then continued with the Gly-X-Y 
structure. A similar type of sequence has also been 
found for CNBr peptide CB4 (not shown). 
The C-terminal peptide CB7 started, according to 
Edman degradation, with two Gly-X-Y segments 
followed by 5 residues of non-triplet nature. The 
entire sequence was completed by degradation of
CB7 with carboxypeptid~ Y (fig.3). The data showed 
5 10 
Pl His-Val-Asp-Met-Gly-Ser-Met-Gly-Gly-Gln- 
15 
Gly-Gly-Asp-Gln-Gly-Glu-Gl.y-Gly- 
5 + 10 
CB7 Gly-Pro-Hyp-Gly-Thr-Hyp-Ser-Val-Asp-His- 
Gly-Ser-Phe-Of? 
15 + 10 
CB5 Gly-Pro-Hyp-Gly-Pro-Gln-Gly-Gln-Hyp-Gly- 
15 20 
Leu-Hyp-Gly-Thr-Hyp-Gly-XXX-Pro-Val-Glu- 
25 30 
Gly-Pro-Pro-Gly-Asp-Gln-Gly-Pro-Gln-Gly- 
Fig.2. Amino acid sequences of pepsin fragment Pl and its 
CNBr peptides CBS and CB?. Stretches which lack the triplet 
structure Gly-X-Y are underlined. XXX denotes an uniden- 
tified residue; *partially hydroxylated proline 
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Digestion time (h) 
Fig.3. Kinetics of carboxypeptidase Y digestion of CNBr pep- 
tide CB7. 
a rapid release of 0.4 residues of Phe in agreement 
with the low content of this amino acid in the pep- 
tide (table 1). This was followed by the liberation of 
serine and glycine indicating that CB7 has the C-ter- 
minal sequence Gly-Ser-Phe. Part of the peptide, 
however, may lack the ultimate amino acid residue 
indicating that pepsin has released fragment Pl from 
type IV collagen by either cleavage at the N- or C-ter- 
minal site of phenylalanine. Data similar to that for 
CB7 were obtained for Pl by kinetic analysis of car- 
boxypeptidase Y digestion. 
4. Discussion 
The data demonstrated tw’o types of discontinuities 
in the triplet sequence Gly-X-Y of the pepsin frag- 
ment Pl from the mouse al (IV) chain. These included 
two longer stretches of 7-8 amino acid residues 
located at both the N- and C-terminus of Pl. A small 
interruption resembling a single deletion of glycine 
was found in the central portion of CNBr peptide 
CBS. Similar data was obtained for another pepsin 
fragment P2 ([ 121, unpublished) which presumably is
a fragment of the mouse (~2 (IV) chain. 
The non-triplet sequences found at both ends of 
Pl resemble the type of structure found in the ter- 
minal, non-helical sequences of the (Y chains of inter- 
stitial collagens [3]. The sequence of the C-terminal 
CNBr peptide CB7 of Pl was completely elucidated. 
This peptide resembles in composition and size other 
C-terminal CNBr peptides for bovine lens capsule C’ 
and C fragments [lo]. These chains are longer than Pl 
and may comprise in the case of C’ (ni, 140 000), the 
whole length of the triple helical domain of the crl 
(IV) chain. Similarly, the triple helix of the mouse 
al (IV) chain [ 121 could be recovered as fragments 
P3A (M, 72 000) and Pl (M, 55 000). Taken together 
the data indicate that Pl is derived from the carboxyl 
end of cwl (IV) chain while C and C’ include the Pl 
segment but extend to the N-terminal region (fig.4). 
The non-helical sequence of peptide CB7 therefore 
resembles the C-terminal non-helical end of the triple 
helix in interstitial collagens and may perhaps continue 
into aprocollagen-like structure [2,3]. The non-helical 
part at the N-terminus of PI, however, indicates a
clear interruption of the triple helix in type IV col- 
lagen. Such an interruption explains the high sensitiv- 
ity of this molecule to proteolytic attack resulting in 
a limited number of distinct fragments [4-l 11. Sim- 
ilar sequence discontinuities have also been identified 
in human placenta type IV collagen [141. 
The short discontinuity of the triple helical 
sequence as found for CNBr peptide CB5 resembles 
that observed in the collagenous segment of the com- 
plement component Clq [22]. Here, the A chain has 
a threonine inserted between two Gly-X-Y segments 
and the B chain has one glycine in the triple helical 
sequence substituted by alanine. These discontinuities 
are considered to be responsible for a bend in the 
triple helical strands of Clq as shown by electron 
microscopy [23,24]. It is still an open question as to 
bovine lens capsule 
t- C’ -i 
I- C + 
NH2 ’ COOH 
SS 
+ P3A + PI -i 
mouse tumor 
Fig.4. Scheme of the triple helical domain in or1 (IV) chain 
and tentative order of pepsin fragments obtained from bovine 
lens capsule [ 101 and mouse EHS sarcoma ([ 121, this report). 
SS denotes interchain disultide bridges. 
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how an interrupted Gly-X-Y sequence affects the 
triple helical conformation and shape of type IV col- 
lagen. Available physical data [ 1,2] do not indicate 
that this protein is less rigid or stable than interstitial 
collagens which lack these sequence interruptions [3 1. 
However, preliminary observations such as the biphasic 
nature of the melting profile of triple helical Pl [ 12 ] 
may reflect helix discontinuity. These kinds of 
sequences are also responsible for the continuous 
degradation of type IV collagen upon prolonged 
exposure to pepsin [12,14]. 
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